Encapsulation of sodium nimesulide and precursors in beta-cyclodextrin.
Susana S Braga, Paulo Ribeiro-Claro, Martyn Pillinger, Isabel S Gonçalves, Florbela Pereira, Ana C Fernandes, Carlos C Romão, Pedro Brito Correia, José J Teixeira-Dias
文献索引:Org. Biomol. Chem. 1(5) , 873-8, (2003)
全文:HTML全文
摘要
Crystalline 1:1 inclusion complexes with beta-cyclodextrin (beta-CD) and the sodium salt of nimesulide (4-nitro-2-phenoxymethanesulfonanilide), and the sodium salt of the derivative 2-phenoxymethanesulfonanilide, have been prepared by co-precipitation from aqueous solution. The presence of true inclusion complexes was supported by elemental analysis, thermogravimetry and powder X-ray diffraction. FTIR and 13C CP MAS NMR spectroscopy confirmed that no chemical modification of the guests occurred upon formation of inclusion complexes. The reaction of the precursors 2-phenoxynitrobenzene and 2-phenoxyaniline with beta-CD was also studied and crystalline inclusion complexes with a 2:1 (host-to-guest) stoichiometry were isolated. The interaction of the different guest species with beta-CD host molecules was studied theoretically by carrying out ab initio calculations. Favourable inclusion geometries were obtained for the four guests mentioned above. On the other hand, it was found that the inclusion of the neutral guests nimesulide and 2-phenoxymethanesulfonanilide was considerably less favourable. This is in agreement with the experimentally observed difficulty in isolating true inclusion complexes containing these guests and beta-CD. The calculated lower stability is attributed to the different steric hindrance arising from the different conformational preferences of neutral and anionic forms.
相关化合物
相关文献:
2002-01-02
[J. Agric. Food Chem. 50(1) , 29-40, (2002)]
The first structurally characterised sodium primary amide complex; synthesis and crystal structure of 2-PhOC6H4NHNa· NMe [(CH2) 2NMe2] 2. Cragg-Hine I, et al.
[J. Chem. Soc., Dalton Trans. 19 , 2901-2, (1994)]
Synthesis and Pharmacological Evaluation of Certain Schiff Bases and Thiazoldine derivatives as AT1 angiotension-II (AII) receptor antagonists. Shreenivas MT, et al.
[J. Pharmaceut. Sci. Tech. 1(2) , 88-94, (2009)]